A comprehensive view of Bausch & Lomb Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Pet Care Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Bausch + Lomb and Modulight announce FDA approval of ML6710i photodynamic laser for use with Bausch + Lomb's Visudyne verteporfin injectable; ML6710i is an easy-to-use, transportable ophthalmic laser controlled from an iPad mobile application
Published: February 03, 2023 by ENP Newswire
Bausch & Lomb to rollout Project Watson health care products for dogs' eyes, ears online in certain retailers in the US, starting next month; line includes eye wash and wipes, ear wash and wipes, an eye health supplement and a multi-health supplement
Published: October 26, 2022 by Pets Plus Magazine
Alcon settles for US$20.0M, J&J Vision settles for US$55.0M, in class-action lawsuit that accused several contact lens makers of anticompetitive price fixing; in 2019 Bausch & Lomb settled for US$10.0M, CooperVision settled for US$3.0M
Published: October 14, 2022 by FierceBiotech
Fitch Downgrades Bausch + Lomb's IDR to 'B-'; Evolving Rating Watch Pre and Post Downgrade
Published: October 07, 2022 by ENP Newswire
Bausch & Lomb launches Revive customizable soft contact lens in US that fit a wide range of patients, including those with high or unique prescriptions; non-ionic material allows lenses to be worn daily for up to three months
Published: June 16, 2022 by Canada StockWatch

Ask us about our Pet Care market view

Trending Chart

Interactive chart with headline count